I'll say; I was expecting +/- 55c on the back of the US DoD writing a blank cheque to get this drug over the finish line.
Then +/- 80c upon further positive results of PCSK9 inhibitor proof of concept study in June/July.
When you consider the sheer lack of shares available to the public if even just one of these drugs reaches the market... It's retirement stock on the dividends alone.
Ann: NYR Secures Collaboration with Walter Reed and UNSW, page-37
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.35M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10869 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.5¢ | 32765 | 3 |
View Market Depth
| Last trade - 10.06am 24/12/2024 (20 minute delay) ? |
| NYR (ASX) Chart |
Day chart unavailable
